ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock VRAYQ vs. AFIB, SDCCQ, GMVDF, AHPI, NMRD, MOTS, UTRS, VIVE, DRTSW, and ANZUWShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include Acutus Medical (AFIB), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Motus GI (MOTS), Minerva Surgical (UTRS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), and Anzu Special Acquisition Corp I (ANZUW). These companies are all part of the "medical equipment" industry. ViewRay vs. Its Competitors Acutus Medical SmileDirectClub G Medical Innovations Allied Healthcare Products Nemaura Medical Motus GI Minerva Surgical Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Acutus Medical (NASDAQ:AFIB) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings, community ranking and risk. Is AFIB or VRAYQ more profitable? ViewRay has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. ViewRay's return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Acutus Medical-272.74% -311.64% -11.57% ViewRay N/A N/A N/A Do insiders & institutionals hold more shares of AFIB or VRAYQ? 56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 15.5% of ViewRay shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Comparatively, 2.5% of ViewRay shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community believe in AFIB or VRAYQ? Acutus Medical received 12 more outperform votes than ViewRay when rated by MarketBeat users. CompanyUnderperformOutperformAcutus MedicalOutperform Votes1232.43% Underperform Votes2567.57% ViewRayN/AN/A Which has better valuation & earnings, AFIB or VRAYQ? Acutus Medical has higher earnings, but lower revenue than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAcutus Medical$7.16M0.01-$81.66MN/AN/AViewRay$102.21M0.00-$107.33MN/AN/A Which has more volatility & risk, AFIB or VRAYQ? Acutus Medical has a beta of -0.35, suggesting that its stock price is 135% less volatile than the S&P 500. Comparatively, ViewRay has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Does the media refer more to AFIB or VRAYQ? In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score. Company Overall Sentiment Acutus Medical Neutral ViewRay Neutral SummaryViewRay beats Acutus Medical on 5 of the 9 factors compared between the two stocks. Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRAYQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18K$3.33B$5.57B$8.51BDividend YieldN/A1.73%5.27%4.15%P/E RatioN/A19.1726.7819.65Price / SalesN/A195.99404.49152.18Price / CashN/A44.0938.2534.64Price / BookN/A3.816.964.59Net Income-$107.33M$94.03M$3.23B$248.23M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300AFIBAcutus MedicalN/A$0.00+12.5%N/A-95.8%$54K$7.16M0.00340Gap UpSDCCQSmileDirectClubN/A$0.00+∞N/A-96.4%$40K$470.74M0.002,700Gap UpGMVDFG Medical InnovationsN/A$0.00flatN/AN/A$26K$4.42M0.0072AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16K$27.05M0.00150Gap UpNMRDNemaura Medical0.9319 of 5 stars$0.00flatN/AN/A$4K$3.02K0.0040MOTSMotus GI0.1063 of 5 stars$0.00flatN/AN/A$2K$319K0.0030UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160VIVEViveve MedicalN/A$0.00flatN/AN/A$1K$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.23+9.0%N/A-7.3%$0.00N/A0.0080Positive NewsGap UpANZUWAnzu Special Acquisition Corp IN/A$0.05-23.0%N/A-2.3%$0.00N/A0.002Gap DownHigh Trading Volume Related Companies and Tools Related Companies Acutus Medical Alternatives SmileDirectClub Alternatives G Medical Innovations Alternatives Allied Healthcare Products Alternatives Nemaura Medical Alternatives Motus GI Alternatives Minerva Surgical Alternatives Viveve Medical Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRAYQ) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRAYQ Stock Free VRAYQ Stock Alerts